FHIR
© HL7.org |
FHIRsmith
4.0.1 |
Server Home
|
XIG Home
|
XIG Stats
|
FHIR IG analytics
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
kr
|
nl
|
no
|
nz
|
pl
|
pt
|
se
|
stt
|
tw
|
uk
|
us
|
uv
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US
21,577 resources (
JSON
|
CSV
)
Type:
Account
ActivityDefinition
ActorDefinition
AdministrableProductDefinition
AdverseEvent
AllergyIntolerance
Appointment
AppointmentResponse
ArtifactAssessment
AuditEvent
Basic
Binary
BiologicallyDerivedProduct
BiologicallyDerivedProductDispense
BodySite
BodyStructure
Bundle
CapabilityStatement
CarePlan
CareTeam
CatalogEntry
ChargeItem
ChargeItemDefinition
Citation
Claim
ClaimResponse
ClinicalImpression
ClinicalUseDefinition
CodeSystem
Communication
CommunicationRequest
Composition
ConceptMap
Consent
Contract
Coverage
CoverageEligibilityRequest
CoverageEligibilityResponse
DetectedIssue
Device
DeviceDefinition
DeviceDispense
DeviceMetric
DeviceRequest
DeviceUsage
DeviceUseStatement
DiagnosticReport
DocumentManifest
DocumentReference
Encounter
EncounterHistory
Endpoint
EnrollmentRequest
EnrollmentResponse
EpisodeOfCare
Evidence
EvidenceVariable
ExampleScenario
ExplanationOfBenefit
FamilyMemberHistory
Flag
GenomicStudy
Goal
GraphDefinition
Group
GuidanceResponse
HealthcareService
ImagingSelection
ImagingStudy
Immunization
ImmunizationEvaluation
ImmunizationRecommendation
ImplementationGuide
Ingredient
InsurancePlan
InsuranceProduct
InventoryItem
InventoryReport
Invoice
Library
Linkage
List
Location
ManufacturedItemDefinition
Measure
MeasureReport
Media
Medication
MedicationAdministration
MedicationDispense
MedicationKnowledge
MedicationRequest
MedicationStatement
MedicinalProductDefinition
MedicinalProductManufactured
MessageDefinition
MessageHeader
MolecularDefinition
MolecularSequence
NamingSystem
NutritionOrder
Observation
ObservationDefinition
OperationDefinition
OperationOutcome
Organization
OrganizationAffiliation
PackagedProductDefinition
Parameters
Patient
PaymentNotice
PaymentReconciliation
Permission
Person
PersonalRelationship
PlanDefinition
Practitioner
PractitionerRole
Procedure
ProcedureRequest
Provenance
Questionnaire
QuestionnaireResponse
ReferralRequest
RegulatedAuthorization
RelatedPerson
RequestGroup
RequestOrchestration
Requirements
ResearchStudy
ResearchSubject
RiskAssessment
Schedule
SearchParameter
ServiceRequest
Slot
Specimen
SpecimenDefinition
StructureDefinition
StructureMap
Subscription
SubscriptionStatus
SubscriptionTopic
Substance
SubstanceDefinition
SupplyDelivery
SupplyRequest
Task
TerminologyCapabilities
TestPlan
TestReport
TestScript
Transport
ValueSet
VerificationResult
VisionPrescription
Text:
Package:
Only Show Used
By Version
R2
: 0
R2B
: 0
R3
: 578
R4
: 19,982
R4B
: 194
R5
: 823
R6
: 0
By Authority
none: 2,208
hl7
: 19,367
national
: 2
Start
Prev
Rows 13600 - 13800
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
Auth
Usage #
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1139.json
ACE Inhibitor or ARB or ARNI
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1140.json
Patient Reason for ACE Inhibitor or ARB Decline
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1141.json
Psychoanalysis
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1151.json
Renal Failure Due to ACE Inhibitor
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1170.json
Tobacco User
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1174.json
Beta Blocker Therapy
active
2021-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1176.json
Heart Rate
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1177.json
Allergy to Beta Blocker Therapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1178.json
Intolerance to Beta Blocker Therapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1184.json
Beta Blocker Therapy for LVSD
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1187.json
Group Psychotherapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1189.json
Tobacco Non User
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1190.json
Tobacco Use Cessation Pharmacotherapy
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1193.json
Cardiac Pacer
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1211.json
Allergy to ACE Inhibitor or ARB
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1212.json
Intolerance to ACE Inhibitor or ARB
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1240.json
Annual Wellness Visit
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1241.json
Acute and Subacute Iridocyclitis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1251.json
Macular Exam
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1259.json
Limited Life Expectancy
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1278.json
Tobacco Use Screening
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1283.json
Level of Severity of Retinopathy Findings
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1285.json
Ophthalmological Services
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1320.json
Macular Edema Findings Present
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1332.json
Cognitive Assessment
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1333.json
Cup to Disc Ratio
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1334.json
Optic Disc Exam for Structural Abnormalities
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1409.json
Burn Confined to Eye and Adnexa
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1410.json
Cataract Secondary to Ocular Disorders
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1411.json
Cataract Surgery
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1412.json
Cataract Congenital
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1413.json
Cataract Mature or Hypermature
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1414.json
Cataract Posterior Polar
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1415.json
Certain Types of Iridocyclitis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1416.json
Chronic Iridocyclitis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1417.json
Cloudy Cornea
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1418.json
Corneal Edema
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1419.json
Disorders of Cornea Including Corneal Opacity
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1423.json
Glaucoma
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1424.json
Hereditary Corneal Dystrophies
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1426.json
Hypotony of Eye
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1427.json
Injury to Optic Nerve and Pathways
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1428.json
Central Corneal Ulcer
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1430.json
Open Wound of Eyeball
active
2021-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1432.json
Pathologic Myopia
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1433.json
Posterior Lenticonus
active
2021-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1438.json
Retrolental Fibroplasias
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1443.json
Traumatic Cataract
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1444.json
Uveitis
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1445.json
Vascular Disorders of Iris and Ciliary Body
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1446.json
Visual Field Defects
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1448.json
Amblyopia
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1450.json
Choroidal Degenerations
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1451.json
Choroidal Detachment
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1452.json
Choroidal Hemorrhage and Rupture
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1453.json
Degeneration of Macula and Posterior Pole
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1454.json
Degenerative Disorders of Globe
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1455.json
Diabetic Macular Edema
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1457.json
Disorders of Optic Chiasm
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1458.json
Disorders of Visual Cortex
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1459.json
Disseminated Chorioretinitis and Disseminated Retinochoroiditis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1460.json
Focal Chorioretinitis and Focal Retinochoroiditis
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1461.json
Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1462.json
Hereditary Choroidal Dystrophies
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1463.json
Hereditary Retinal Dystrophies
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1465.json
Nystagmus and Other Irregular Eye Movements
active
2021-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1466.json
Optic Atrophy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1467.json
Optic Neuritis
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1468.json
Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1469.json
Other Background Retinopathy and Retinal Vascular Changes
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1471.json
Other Disorders of Optic Nerve
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1473.json
Other Endophthalmitis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1475.json
Prior Penetrating Keratoplasty
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1477.json
Purulent Endophthalmitis
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1478.json
Retinal Detachment with Retinal Defect
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1479.json
Retinal Vascular Occlusion
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1480.json
Other Proliferative Retinopathy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1482.json
Separation of Retinal Layers
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1483.json
Visual Acuity 20/40 or Better
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1491.json
Major Depressive Disorder Active
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1492.json
Psych Visit Diagnostic Evaluation
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1496.json
Psych Visit Psychotherapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1530.json
Speech and Hearing Evaluation
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1558.json
Morgagnian Cataract
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1559.json
Macular Scar of Posterior Polar
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1560.json
Best Corrected Visual Acuity Exam Using Snellen Chart
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1561.json
Medications for Above Normal BMI
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1562.json
Medications for Below Normal BMI
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1563.json
Underweight
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1566.json
Adult Depression Medications
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1567.json
Adolescent Depression Medications
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1568.json
Follow Up for Adult Depression
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1569.json
Follow Up for Adolescent Depression
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1570.json
Referral for Adolescent Depression
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1571.json
Referral for Adult Depression
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1572.json
High Intensity Statin Therapy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1573.json
LDL Cholesterol
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1574.json
Low Intensity Statin Therapy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1575.json
Moderate Intensity Statin Therapy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1576.json
Outpatient Encounters for Preventive Care
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1578.json
Follow Up Within 4 Weeks
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1580.json
Referral to Primary Care or Alternate Provider
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1581.json
Lifestyle Recommendation
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1582.json
Patient Declined
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1583.json
Referral or Counseling for Alcohol Consumption
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1584.json
Hospice Care Ambulatory
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.3000.json
Metformin
active
2019-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.319.json
Prostate Cancer
active
2020-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.320.json
Bone Scan
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.326.json
Primary Open Angle Glaucoma
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.327.json
Diabetic Retinopathy
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.353.json
End Stage Renal Disease
active
2020-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.362.json
Asthma
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.366.json
Arrhythmia
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.367.json
Atrioventricular Block
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.368.json
Cardiac Pacer in Situ
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.369.json
Coronary Artery Disease No MI
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.370.json
Hypotension
active
2020-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.371.json
Cardiac Surgery
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.376.json
Heart Failure
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.398.json
Prostate Cancer Treatment
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.399.json
Salvage Therapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.401.json
Prostate Specific Antigen Test
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.403.json
Initial Myocardial Infarction
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.412.json
Bradycardia
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.451.json
Pain Warranting Further Investigation for Prostate Cancer
active
2020-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.471.json
Bilateral Oophorectomy
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.526.3.485.json
Chemotherapy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1498.json
Medications for Above Normal BMI
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1499.json
Medications for Below Normal BMI
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1519.json
Follow Up for Above Normal BMI
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1523.json
Follow Up for Above Normal BMI
active
2017-08
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1524.json
Follow Up for BMI Outside Normal Parameters
active
2024-02
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1525.json
Follow Up for Above Normal BMI
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1526.json
Follow Up for Above Normal BMI
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1527.json
Referrals Where Weight Assessment May Occur
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1528.json
Follow Up for Below Normal BMI
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1549.json
Follow Up for Below Normal BMI
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1550.json
Follow Up for Below Normal BMI
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1551.json
Follow Up for Below Normal BMI
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1578.json
Palliative Care
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1579.json
Palliative or Hospice Care
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1608.json
Encounter to Document Medications
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1609.json
Encounter to Document Medications
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1610.json
Referrals Where Weight Assessment May Occur
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1751.json
Encounter to Evaluate BMI
active
2024-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1834.json
Encounter to Document Medications
active
2024-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1917.json
Encounter to Document Medications
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.695.json
Encounter to Evaluate BMI
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.885.json
Encounter to Evaluate BMI
active
2018-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1.886.json
Encounter to Evaluate BMI
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1475.json
Referral to Primary Care or Alternate Provider
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1476.json
Pharmacologic Therapy for Hypertension
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1482.json
Laboratory Tests for Hypertension
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1497.json
Encounter to Screen for Blood Pressure
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1508.json
Lifestyle Recommendation
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1509.json
Weight Reduction Recommended
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1510.json
Weight Reduction Recommended
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1511.json
Dietary Recommendations
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1512.json
Dietary Recommendations
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1514.json
Dietary Recommendations
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1515.json
Dietary Recommendations
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1516.json
Exercise Class
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1518.json
Recommendation to Increase Physical Activity
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1537.json
Follow Up Within 4 Weeks
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1538.json
Encounter to Screen for Depression
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1914.json
Encounter to Screen for Depression
active
2020-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1915.json
Encounter to Screen for Depression
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1916.json
Encounter to Screen for Depression
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1918.json
Encounter to Screen for Blood Pressure
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.192.json
Encounter to Screen for Blood Pressure
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.1920.json
Encounter to Screen for Blood Pressure
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.2387.json
Overweight or Obese
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.2388.json
Underweight
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.2395.json
Finding of Hypertension
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.2462.json
Laboratory Tests for Hypertension
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.2466.json
Dental Tooth Extraction
active
2022-02
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.259.json
Diagnosis of Hypertension
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.261.json
Diagnosis of Hypertension
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.263.json
Diagnosis of Hypertension
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.467.json
Follow Up for Adolescent Depression
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.468.json
Follow Up for Adult Depression
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.469.json
Adolescent Depression Medications
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.470.json
Adult Depression Medications
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.537.json
Referral for Adolescent Depression
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.538.json
Referral for Adult Depression
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.791.json
Patient Declined
active
2025-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.805.json
Weight Reduction Recommended
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.810.json
Recommendation to Increase Physical Activity
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.600.823.json
Referral or Counseling for Alcohol Consumption
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.6366.117.json
Absence of Cervix
active
2024-08
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.1743.json
General or Neuraxial Anesthesia
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.1940.json
Immunocompromised Conditions
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.2262.json
CABG Surgeries
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.2328.json
Immunocompromised Conditions I10
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.2343.json
Immunocompromised Conditions
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.3011.json
Acute Myocardial Infarction
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.3024.json
Acute Myocardial Infarction
active
2016-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.307.json
Encounter Inpatient
active
2020-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.666.5.335.json
Bone Marrow Transplant
active
2021-09
hl7
1
FHIR IG analytics
FHIR
FHIRsmith